Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Iodine exploration and production company Iofina swung to a first-half profit on record revenue.
For the six months ended 30 June 2020, pre-tax profit was $1.32m, compared with a loss of $0.30 million year-on-year as revenue increased by 8% to $15.74 million.
Sales of iodine products increased by 4% to $10.27 million.
'The iodine market was robust pre-COVID-19 and remained fairly strong through Q2 2020. Demand for iodine and iodine-based products has seemingly slowed slightly in Q3 2020 and, as a result, large volume iodine prices have fallen marginally from $35-37/kg in early Q3 to $33-35/kg currently,' the company said.
There were no plans to invest further in IofinaEX given the regulatory uncertainty and low pricing environment for hemp-based products in the USA, it added.
'Despite a challenging global trading environment caused by COVID-19 we continued to execute our strategy effectively, reflected in the financial highlights and in our levels of iodine produced,' Iofina said.
'The record revenues and EBITDA achieved by the group is a result of business strategies implemented over the last few years and the efficiency of our IOsorb plants.'
At 9:15am: (LON:IOF) Iofina PLC share price was +0.25p at 14p